CytRx Corporation Share Price Nasdaq
Equities
US2328286081
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 644K 51.23M |
---|---|---|---|---|---|
Net income 2022 | -4M -318M | Net income 2023 | - 0 | EV / Sales 2022 | - |
Net cash position 2022 | 1.15M 91.17M | Net cash position 2023 | 2.04M 162M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.05
x | P/E ratio 2023 |
1.91
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.44% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Snowdy
CEO | Chief Executive Officer | 55 | 09/01/22 |
John Caloz
DFI | Director of Finance/CFO | 72 | 30/09/07 |
Cristina Newman
SEC | Corporate Secretary | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jennifer Simpson
CHM | Chairman | 55 | 28/07/21 |
Cary Claiborne
BRD | Director/Board Member | 64 | 26/07/22 |
Joel Caldwell
BRD | Director/Board Member | 69 | 11/07/17 |
1st Jan change | Capi. | |
---|---|---|
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |